BOSIDENG

Bosideng closed at HKD 4.94, up 0.41%, sustained by recent earnings beat and institutional rerating. Full-year results showed net profit surged 24.54% year-over-year, with new product categories hitting record 63% mix and the 'Puff' line exceeding RMB 200 million in sales. Multiple brokers rerated upward: Goldman Sachs and HSBC raised targets to HKD 5.3, while JPMorgan set its target at HKD 6.4, implying 7-30% upside from current levels. Positionally, the stock has gained 9.29% year-to-date, still 8% below the 52-week high of HKD 5.37, having rebounded 39% from June lows. With PE of 12.76x, dividend yield of 5.68% and ROE exceeding 30%, fundamentals remain sound.

Bosideng edged up 0.2% on July 30 to close at HK$4.92, trading within a narrow HK$4.86–4.94 range as the market digested fiscal-year results and mounting analyst upgrades. Over three consecutive days from July 26 to 28, Goldman Sachs, UBS, and HSBC lifted price targets to HK$5.30–5.61, while JPMorgan raised its to HK$6.40, all driven by strong FY2026 earnings: net profit surged 24.5% year-over-year, EPS grew 21.98%, new product categories reached a record 63% of sales mix, and the 'Puff' line surpassed RMB2 billion in revenue. Positionally, the stock trades 8.38% below its 52-week high of HK$5.37 despite an 8.85% year-to-date gain, suggesting price appreciation significantly lags profit growth momentum. A headwind: the stock's turnover rate of just 0.16% signals weak liquidity, which may constrain near-term upside potential.

Bosideng rose to HKD4.90 today (+2.08%), extending recent strength. The primary driver is the recently released FY2025/26 annual results, which showed net profit climbing 24.54% YoY to HKD1.59 billion, operating revenue up 14.06% to HKD10.44 billion, with an announced dividend of HKD0.25 per share. The strong results sparked multiple institutions to raise target prices: both Goldman Sachs and HSBC lifted targets to HKD5.3, while JPMorgan raised to HKD6.4, all maintaining Buy ratings. New product categories reached a record 63% sales mix, with the 'Puff' line surpassing RMB2 billion in sales. From a price perspective, the stock trades 8.75% below its 52-week high of HKD5.37, up 8.41% year-to-date and above the 60-day moving average. The valuation shows a modest PE of 12.66x, though recent turnover rate of 0.13% suggests limited participation.

Bosideng rose 1.05% to HK$4.80 today, supported by a cluster of institutional price-target upgrades in recent weeks—Goldman Sachs and HSBC each lifted targets to HK$5.3, JPMorgan took a more bullish stance at HK$6.4, and UBS raised its target to HK$5.61. These upgrades are anchored in the company's strong FY2026 results: operating revenue grew 14.06% year-over-year, net profit surged 24.54%, and ROE reached 30.71%; the 'Puff' down jacket line also crossed RMB 2 billion in sales, underpinning momentum in new product categories. Intraday trading reflected cautious optimism, with the stock hitting a session high of HK$4.84 in the morning before settling back to the close. In terms of valuation, the stock is up 6.19% year-to-date and still sits about 10.6% below its 52-week peak of HK$5.37; at a PE of 12.4x and PB of 2.71x, it retains relative attractiveness. That said, Morgan Stanley recently cut its target to HK$5.1 and lowered sales and earnings forecasts, reflecting lingering investor skepticism about the durability of growth.

Bosideng closed at HKD 4.75, down from open at HKD 4.88, reflecting a pullback of roughly 2.7%. This represents profit-taking following a robust rally triggered by strong full-year results and analyst upgrades — Goldman Sachs and UBS both raised target prices to HKD 5.3 and HKD 5.61 respectively, with JPM more bullishly upgraded to HKD 6.4. The FY2026 results showed revenue of HKD 10.44 billion (+14.06% YoY), net profit of HKD 1.59 billion (+24.54% YoY) hitting a record, with net margin steady at 15.23%, ROE of 30.71%, and EPS growing 21.98% YoY. The new 'Puff' product line surpassed RMB 2 billion in sales, while new categories reached a record-high mix of 63%. From a valuation perspective, the stock has risen 5.09% year-to-date but trades 11.55% below its 52-week high of HKD 5.37, with the uptrend intact. Moderating turnover today suggests the market is digesting recent analyst recommendations while awaiting fresh catalysts.